RhumbLine Advisers
ORGO icon

RhumbLine Advisers’s Organogenesis Holdings ORGO Stock Holding History

RhumbLine Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
85,660
+5,645
+7% +$13.8K ﹤0.01% 3264
2026
Q1 		$190K Sell
80,015
-7,853
-9% -$27.2K ﹤0.01% 3148
2025
Q4 		$455K Sell
87,868
-14,662
-14% -$71K ﹤0.01% 2723
2025
Q3 		$433K Sell
102,530
-2,682
-3% -$12.5K ﹤0.01% 2786
2025
Q2 		$385K Sell
105,212
-7,173
-6% -$26.7K ﹤0.01% 2846
2025
Q1 		$485K Sell
112,385
-2,881
-2% -$11.6K ﹤0.01% 2593
2024
Q4 		$369K Buy
115,266
+7,621
+7% +$25.6K ﹤0.01% 2854
2024
Q3 		$308K Sell
107,645
-5,367
-5% -$15.1K ﹤0.01% 3011
2024
Q2 		$316K Buy
113,012
+3,436
+3% +$9.22K ﹤0.01% 2965
2024
Q1 		$311K Buy
109,576
+3,151
+3% +$10.7K ﹤0.01% 2959
2023
Q4 		$435K Sell
106,425
-1,030
-1% -$2.88K ﹤0.01% 2742
2023
Q3 		$342K Buy
107,455
+2,841
+3% +$9.03K ﹤0.01% 2855
2023
Q2 		$347K Buy
104,614
+15,910
+18% +$47K ﹤0.01% 2919
2023
Q1 		$189K Sell
88,704
-122,083
-58% -$302K ﹤0.01% 2749
2022
Q4 		$567K Buy
210,787
+16,099
+8% +$47K ﹤0.01% 2407
2022
Q3 		$631K Buy
194,688
+16,804
+9% +$75.9K ﹤0.01% 2389
2022
Q2 		$868K Buy
177,884
+19,833
+13% +$122K ﹤0.01% 2212
2022
Q1 		$1.2M Buy
158,051
+39,208
+33% +$303K ﹤0.01% 2058
2021
Q4 		$1.1M Buy
118,843
+3,481
+3% +$37K ﹤0.01% 2169
2021
Q3 		$1.64M Sell
115,362
-2,275
-2% -$35.3K ﹤0.01% 2004
2021
Q2 		$1.96M Buy
117,637
+99,993
+567% +$1.86M ﹤0.01% 1962
2021
Q1 		$321K Buy
17,644
+3,556
+25% +$48.2K ﹤0.01% 2681
2020
Q4 		$106K Buy
14,088
+1,760
+14% +$8.36K ﹤0.01% 2964
2020
Q3 		$47K Sell
12,328
-3,495
-22% -$13.8K ﹤0.01% 2953
2020
Q2 		$61K Buy
+15,823
New +$57.1K ﹤0.01% 3018

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

RhumbLine Advisers's ORGO Position: Q2 2026 in Review

RhumbLine Advisers increased its Organogenesis Holdings (ORGO) stake by 7.1% in Q2 2026, buying an estimated $13.8K and bringing the position to 85,660 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3264.

RhumbLine Advisers first reported a position in ORGO in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.96M in Q2 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • RhumbLine Advisers held 85,660 shares of Organogenesis Holdings worth $208K as of Q2 2026.
  • RhumbLine Advisers bought 5,645 Organogenesis Holdings shares in Q2 2026, an estimated $13.8K.
  • Organogenesis Holdings made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3264 holding.
  • RhumbLine Advisers first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 25 quarters since.
  • RhumbLine Advisers's Organogenesis Holdings position peaked at $1.96M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.